FOLH1 and glioma: Finally, the above radiolabelled derivatives have been tested in vivo in two preclinical cancer models (prostate and high grade glioma), to evaluate their pharmacokinetic properties, also by comparison with above mentioned well known and routinely used [18F]F-PSMA-1007.